These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Local changes at the site of pentazocine injection. Schlicher JE, Zuehlke RL, Lynch PJ. Arch Dermatol; 1971 Jul; 104(1):90-1. PubMed ID: 5120170 [No Abstract] [Full Text] [Related]
17. Pentazocine fibrous myopathy: report of two cases and literature review. de Lateur BJ, Halliday WR. Arch Phys Med Rehabil; 1978 Aug 30; 59(8):394-7. PubMed ID: 687053 [Abstract] [Full Text] [Related]
18. Pentazocine for the relief of pain following urological procedures. Wilkey JL, Barson LJ, Rowe FH. J Urol; 1967 Mar 30; 97(3):550-1. PubMed ID: 6019619 [No Abstract] [Full Text] [Related]
19. Pentazocine induced widespread cutaneous and myo-fibrosis. Jain A, Bhattacharya SN, Singal A, Baruah MC, Bhatia A. J Dermatol; 1999 Jun 30; 26(6):368-70. PubMed ID: 10405482 [Abstract] [Full Text] [Related]
20. Characteristics of pentazocine dependence in hospitalized patients after naloxone administration. Sandoval RG, Wang RI. Psychopharmacologia; 1973 Jun 19; 30(3):205-15. PubMed ID: 4577443 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]